Inventiva S.A. (NASDAQ:IVA) Q4 2025 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Inventiva Full Year 2025 Financial Report Webcast and Conference Call.
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Samsara BioCapital Srini Akkaraju And Michael Dybbs | 5,194,805 | $28,831,168 | 2.8% | |
| 2. | Caligan Partners David Johnson | 4,974,906 | $27,610,728 | +149% | 1.84% |
| 3. | Paradigm Biocapital Advisors Senai Asefaw | 4,000,000 | $22,200,000 | 0.45% | |
| 4. | Millennium Management Israel Englander | 2,987,613 | $16,581,252 | +13% | 0.01% |
| 5. | Trails Edge Capital Partners Ortav (Tavi) Yehudai | 2,657,997 | $14,751,883 | 3.38% |
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 2,461,565 | $13,661,686 | 0% | |
| 2. | 2,354,000 | $13,064,700 | 24.76% | |
| 3. | 2,318,693 | $12,868,746 | 0% | |
| 4. | 1,818,181 | $10,090,905 | 5.7% | |
| 5. | 1,470,407 | $8,160,759 | 0.11% |